Literature DB >> 22945329

The many faces of heart failure with preserved ejection fraction.

Amil M Shah1, Marc A Pfeffer.   

Abstract

By definition, patients with heart failure and preserved ejection fraction are characterized by a normal or near-normal left ventricular ejection fraction, but marked heterogeneity in the extent of other cardiac structural and functional abnormalities exists. Improved appreciation of this diversity might provide insights into prognosis and therapeutic interventions.

Entities:  

Mesh：

Year:  2012        PMID： 22945329     DOI： 10.1038/nrcardio.2012.123

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


  10 in total

1.  Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction.

Authors:  Michael R Zile; John S Gottdiener; Scott J Hetzel; John J McMurray; Michel Komajda; Robert McKelvie; Catalin F Baicu; Barry M Massie; Peter E Carson
Journal:  Circulation       Date:  2011-11-07       Impact factor: 29.690

Review 2.  Epidemiology and clinical course of heart failure with preserved ejection fraction.

Authors:  Carolyn S P Lam; Erwan Donal; Elisabeth Kraigher-Krainer; Ramachandran S Vasan
Journal:  Eur J Heart Fail       Date:  2010-08-03       Impact factor: 15.534

3.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.

Authors:  John J V McMurray; Stamatis Adamopoulos; Stefan D Anker; Angelo Auricchio; Michael Böhm; Kenneth Dickstein; Volkmar Falk; Gerasimos Filippatos; Cândida Fonseca; Miguel Angel Gomez-Sanchez; Tiny Jaarsma; Lars Køber; Gregory Y H Lip; Aldo Pietro Maggioni; Alexander Parkhomenko; Burkert M Pieske; Bogdan A Popescu; Per K Rønnevik; Frans H Rutten; Juerg Schwitter; Petar Seferovic; Janina Stepinska; Pedro T Trindade; Adriaan A Voors; Faiez Zannad; Andreas Zeiher
Journal:  Eur Heart J       Date:  2012-05-19       Impact factor: 29.983

4.  Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota.

Authors:  Carolyn S P Lam; Véronique L Roger; Richard J Rodeheffer; Francesca Bursi; Barry A Borlaug; Steve R Ommen; David A Kass; Margaret M Redfield
Journal:  Circulation       Date:  2007-04-02       Impact factor: 29.690

Review 5.  Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment.

Authors:  Barry A Borlaug; Walter J Paulus
Journal:  Eur Heart J       Date:  2010-12-07       Impact factor: 29.983

6.  Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence:results from the CHARM Echocardiographic Substudy-CHARMES.

Authors:  Hans Persson; Eva Lonn; Magnus Edner; Lawrence Baruch; Chim C Lang; John J Morton; Jan Ostergren; Robert S McKelvie
Journal:  J Am Coll Cardiol       Date:  2007-01-26       Impact factor: 24.094

7.  Angiotensin receptor blockers and outcomes in real-world older patients with heart failure and preserved ejection fraction: a propensity-matched inception cohort clinical effectiveness study.

Authors:  Kanan Patel; Gregg C Fonarow; Dalane W Kitzman; Inmaculada B Aban; Thomas E Love; Richard M Allman; Mihai Gheorghiade; Ali Ahmed
Journal:  Eur J Heart Fail       Date:  2012-07-03       Impact factor: 15.534

8.  Congestive heart failure with normal systolic function.

Authors:  A H Dougherty; G V Naccarelli; E L Gray; C H Hicks; R A Goldstein
Journal:  Am J Cardiol       Date:  1984-10-01       Impact factor: 2.778

9.  Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure.

Authors:  Scott D Solomon; Joanna Dobson; Stuart Pocock; Hicham Skali; John J V McMurray; Christopher B Granger; Salim Yusuf; Karl Swedberg; James B Young; Eric L Michelson; Marc A Pfeffer
Journal:  Circulation       Date:  2007-08-27       Impact factor: 29.690

10.  Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic.

Authors:  Margaret M Redfield; Steven J Jacobsen; John C Burnett; Douglas W Mahoney; Kent R Bailey; Richard J Rodeheffer
Journal:  JAMA       Date:  2003-01-08       Impact factor: 56.272
  10 in total
  35 in total

Review 1.  Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap.

Authors:  Sanjiv J Shah; Dalane W Kitzman; Barry A Borlaug; Loek van Heerebeek; Michael R Zile; David A Kass; Walter J Paulus
Journal:  Circulation       Date:  2016-07-05       Impact factor: 29.690

2.  Phenomapping for novel classification of heart failure with preserved ejection fraction.

Authors:  Sanjiv J Shah; Daniel H Katz; Senthil Selvaraj; Michael A Burke; Clyde W Yancy; Mihai Gheorghiade; Robert O Bonow; Chiang-Ching Huang; Rahul C Deo
Journal:  Circulation       Date:  2014-11-14       Impact factor: 29.690

3.  Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction: Detailed Phenotypes, Prognosis, and Response to Spironolactone.

Authors:  Jordana B Cohen; Sarah J Schrauben; Lei Zhao; Michael D Basso; Mary Ellen Cvijic; Zhuyin Li; Melissa Yarde; Zhaoqing Wang; Priyanka T Bhattacharya; Diana A Chirinos; Stuart Prenner; Payman Zamani; Dietmar A Seiffert; Bruce D Car; David A Gordon; Kenneth Margulies; Thomas Cappola; Julio A Chirinos
Journal:  JACC Heart Fail       Date:  2020-01-08       Impact factor: 12.035

4.  Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) Trial.

Authors:  Amil M Shah; Brian Claggett; Nancy K Sweitzer; Sanjiv J Shah; Inder S Anand; Eileen O'Meara; Akshay S Desai; John F Heitner; Guichu Li; James Fang; Jean Rouleau; Michael R Zile; Valetin Markov; Vyacheslav Ryabov; Gilmar Reis; Susan F Assmann; Sonja M McKinlay; Bertram Pitt; Marc A Pfeffer; Scott D Solomon
Journal:  Circ Heart Fail       Date:  2014-08-13       Impact factor: 8.790

Review 5.  Phenotypic spectrum of heart failure with preserved ejection fraction.

Authors:  Sanjiv J Shah; Daniel H Katz; Rahul C Deo
Journal:  Heart Fail Clin       Date:  2014-05-22       Impact factor: 3.179

Review 6.  Heart Failure With Preserved Ejection Fraction In Perspective.

Authors:  Marc A Pfeffer; Amil M Shah; Barry A Borlaug
Journal:  Circ Res       Date:  2019-05-24       Impact factor: 17.367

7.  Haemodynamics of Heart Failure With Preserved Ejection Fraction: A Clinical Perspective.

Authors:  Mauro Gori; Attilio Iacovoni; Michele Senni
Journal:  Card Fail Rev       Date:  2016-11

8.  Coding proposal on phenotyping heart failure with preserved ejection fraction: A practical tool for facilitating etiology-oriented therapy.

Authors:  Junbo Ge
Journal:  Cardiol J       Date:  2020       Impact factor: 2.737

Review 9.  Current Management and Future Directions of Heart Failure With Preserved Ejection Fraction: a Contemporary Review.

Authors:  Chayakrit Krittanawong; Marrick L Kukin
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-03-20

Review 10.  Ventricular remodeling in heart failure with preserved ejection fraction.

Authors:  Amil M Shah
Journal:  Curr Heart Fail Rep       Date:  2013-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.